Using both conditional genetic inactivation of VIPR2 in ILC3 and chemogenetic-mediated inhibition of VIP-producing neurons, we found that hepatic steatosis can be attenuated by modulation of VIPergic signaling in innate lymphoid cells. Here, VIP is linked to fatty liver disease.